Characteristics of hearing loss in HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome

Audiology and Neurotology

Volumn 11, Issue 6, 2006, Pages 373-379

  Van Looij, Marjolein A J ^a   Meijers Heijboer, Hanne ^a   Beetz, Rolf ^b   Thakker, Rajesh V ^c   Christie, Paul T ^c   Feenstra, Lou W ^a   Van Zanten, Bert G A ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Audiometry; GATA3; HDR syndrome; Outer hair cells

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED OTOACOUSTIC EMISSION; FEMALE; GENETIC DISORDER; HDR SYNDROME; HEARING LOSS; HISTOLOGY; HUMAN; HYPOPARATHYROIDISM; KIDNEY DYSPLASIA; MALE; MEDICAL RECORD; NOISE; PERCEPTION DEAFNESS; PHENOTYPE; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; SPEECH; SPEECH AUDIOMETRY; SPEECH DISCRIMINATION; SYNDROME;

ADULT; AUDIOMETRY, PURE-TONE; AUDIOMETRY, SPEECH; AUDITORY THRESHOLD; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; GATA3 TRANSCRIPTION FACTOR; HEARING LOSS, SENSORINEURAL; HUMANS; HYPOPARATHYROIDISM; MALE; MULTICYSTIC DYSPLASTIC KIDNEY; NOISE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PHENOTYPE; SYNDROME;

EID: 33750248983     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000095899     Document Type: Article

References (21)

1. Barakat AY, D'Albora JB, Martin MM, Jose PA: Familial nephrosis, nerve deafness, and hypoparathyroidism. J Pediatr 1977;91:61-64.
2. Beetz R, Zorowka P, Schönberger W, Kruse K, Wilichowski E, Zabel B, Mannhardt W, Schumacher R: Hypoparathyreoidismus und Innenohrschwerhö rigkeit. Monatsschr Kinderheilkd 1997;145:347-352.
3. Bilous RW, Murty G, Parkinson DB, Thakker RV, Coulthard MG, Burn J, Mathias D, Kendall-Taylor P: Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia. N Engl J Med 1992;327:1069-1074.
4. Fujimoto S, Yokochi K, Morikawa H, Nakano M, Shibata H, Togari H, Wada Y: Recurrent cerebral infarctions and del(10)(p14p15.1) de novo in HDR (hypoparathyroidism, sensorineural deafness, renal dysplasia) syndrome. Am J Med Gen 1999;86:427-429.
5. Harrison RV, Aran JM, Erre JP: AP tuning curves from normal and pathological human and guinea pig cochleas. J Acoust Soc Am 1981;69:1374-1385.
6. Harrison RV, Aran JM, Negrevergne M: The frequency selectivity of the normal and pathological human cochlea. Arch Otorhinolaryngol 1981;230:221-227.
7. Hasegawa T, Hasegawa Y, Aso T, Koto S, Nagai T, Tsuchiya Y, Kim KC, Ohashi H, Wakui K, Fukushima Y: HDR syndrome (hypoparathyroidism, sensorineural deafness, renal dysplasia) associated with del(10)(p13). Am J Med Genet 1997;73:416-418.
8. Kamphoven JHJ, de Ruiter MM, Winkel LPF, Van den Hout HMP, Bijman J, De Zeeuw CI, Hoeve LJ, Van Zanten GA, Van der Ploeg AT, Reuser AJJ: Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse. Neurobiol Dis 2004;16:14-20.
9. Keats BJB, Savas S: Genetic heterogeneity in Usher syndrome. Am J Med Genet A 2004;130A:13-16.
10. Lichtner P, Konig R, Hasegawa T, Van Esch H, Meitinger T, Schuffenhauer S: An HDR (hypoparathyroidism, deafness, renal dysplasia) syndrome locus maps distal to the Di-George syndrome region on 10p13/14. J Med Genet 2000;37:33-37.
11. Mino Y, Kuwahara T, Mannami T, Shioji K, Ono K, Iwai N: Identification of a novel insertion mutation in GATA3 with HDR syndrome. Clin Exp Nephrol 2005;9:58-61.
12. Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, Yamamoto K, Fujimoto S, Seishu S, Fukushima Y, Hasegawa Y, Ogata T: GATA3 abnormalities and the phenotypic spectrum of HDR syndrome. J Med Genet 2001;38:374-380.
13. Nesbit MA, Bowl MR, Harding B, Ali A, Ayala A, Crowe C, Dobbie A, Hampson G, Holdaway I, Levine MA, McWilliams R, Rigden S, Sampson J, Williams AJ, Thakker RV: Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. J Biol Chem 2004;279:22624-22634.
14. Peltomaa M, Pyykkö I, Seppälä I, Viitanen L, Viljanen M: Lyme borreliosis, an etiological factor in sensorineural hearing loss? Eur Arch Otorhinolaryngol 2000;257:317-322.
15. Plomp R, Mimpen AM: Improving the reliability of testing the speech reception threshold for sentences. Audiology 1979;18:43-52.
16. Steel KP: Inherited hearing defects in mice. Annu Rev Genet 1995;29:675-701.
17. Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, Shaw NJ, Fryns JP, Van de VenW, Thakker RV, Devriendt K: GATA3 haplo-insufficiency causes human HDR syndrome. Nature 2000;406:419-422.
18. Van Looij MAJ, van der Burg H, van der Giessen RS, de Ruiter MM, van der Wees J, van Doorninck JH, de Zeeuw CI, van Zanten GA: GATA3 haploinsufficiency causes a rapid deterioration of distortion product otoacoustic emissions (DPOAEs) in mice. Neurobiol Dis 2005;20:890-897.
19. Van der Wees J, van Looij MAJ, de Ruiter MM, Elias H, van der Burg H, Liem SS, Kurek D, Engel JD, Karis A, van Zanten GA, de Zeeuw CI, Grosveld FG, van Doorninck JH: Hearing loss following GATA3 haploinsufficiency is caused by cochlear disorder. Neurobiol Dis 2004;16:169-178.
20. Yumita S, Furukawa Y, Sohn HE, Unakami H, Miura R, Yoshinaga K: Familial idiopathic hypoparathyroidism and progressive sensorineural deafness. Tohoku J Exp Med 1986;148:135-141.
21. Zahirieh A, Nesbit MA, Ali A, Wang K, He N, Stangou M, Bamichas G, Sombolos K, Thakker RV, Pei Y: Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome. J Clin Endocrinol Metab 2005;90:2445-2450.